Individuals diagnosed with gastroparesis, bowel obstruction, NAION, pancreatitis, or other serious complications may pursue damages connected to hospitalization, surgery, long-term treatment, and ongoing medical care
Important safety considerations include: tirzepatide is not indicated for type 1 diabetes or treatment of diabetic ketoacidosis, and it is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Gentle yet effective formula: Contains panthenol, glycerin and allantoin to soothe, hydrate and support the skin barrier, delivering results without irritation
For up-to-date safety information, eligibility criteria, and program guidelines, visit the official Brello Health website